How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/midazolam-fentanyl-combination.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Midazolam+Fentanyl Combination — Competitive Intelligence Brief

Midazolam+Fentanyl Combination (Midazolam+Fentanyl Combination) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Benzodiazepine + Opioid combination. Area: Anesthesia, Sedation, Pain Management.

marketed Benzodiazepine + Opioid combination GABA-A receptor (midazolam); Mu-opioid receptor (fentanyl) Anesthesia, Sedation, Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Midazolam+Fentanyl Combination (Midazolam+Fentanyl Combination) — Universidad de Cartagena. Midazolam and fentanyl work synergistically as a benzodiazepine and opioid combination to produce sedation, analgesia, and anxiolysis through GABA and opioid receptor agonism.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Midazolam+Fentanyl Combination TARGET	Midazolam+Fentanyl Combination	Universidad de Cartagena	marketed	Benzodiazepine + Opioid combination	GABA-A receptor (midazolam); Mu-opioid receptor (fentanyl)
midazolam + pethidine	midazolam + pethidine	Erasme University Hospital	marketed	Benzodiazepine + Opioid combination	GABA-A receptor (midazolam); mu opioid receptor (pethidine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Benzodiazepine + Opioid combination class)

Erasme University Hospital · 1 drug in this class
Universidad de Cartagena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Midazolam+Fentanyl Combination — Competitive Intelligence Brief. https://druglandscape.com/ci/midazolam-fentanyl-combination. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab